جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

مقالمفتوح (مستودع)2026

New Chromene Derivatives as Promising VEGFR‐2 Inhibitors: Experimental Cytotoxicity and Comprehensive Computational Characterization

Archiv der Pharmazie · مجلد 359 (9) · e70328-e70328

ABSTRACT A new series of chromene derivatives ( 12–19 ) was rationally designed as potential inhibitors of vascular endothelial growth factor receptor‐2 (VEGFR‐2) by integrating essential pharmacophoric and structural features. The target compounds were synthesized and structurally confirmed using spectroscopic techniques. Their in vitro antiproliferative activities were evaluated against a panel of human cancer cell lines (MCF‐7, MDA‐MB‐231, HepG‐2, and HCT‐116) alongside normal human cells (WI‐38 and WISH), in addition to a VEGFR‐2 enzyme inhibition assay. Among the synthesized derivatives, compound 17 emerged as the most potent candidate, displaying low micromolar IC 50 values across all tested cancer cell lines and superior VEGFR‐2 inhibitory activity (IC 50 = 0.518 µM) compared with the reference drug sorafenib (IC 50 = 0.809 µM). Mechanistic investigations revealed that compound 17 induced pronounced cell cycle arrest and triggered apoptosis, as demonstrated by Annexin V–FITC/PI flow cytometric analysis. Computationally, Density Functional Theory (DFT) calculations demonstrated favorable electronic properties for compound 17, supporting effective ligand–receptor interactions. Molecular docking and 100‐ns molecular dynamics (MD) simulations, complemented by MM‐GBSA binding free energy calculations, Protein–Ligand Interaction Fingerprinting (Pro‐LIF), Principal Component Analysis (PCA‐T), and Free Energy Landscape (FEL) analyses, confirmed the stability and favorable binding energetics of compound 17 within the VEGFR‐2 active site. Furthermore, in silico ADME–Tox profiling predicted acceptable pharmacokinetic behavior and a favorable safety profile. Collectively, these experimental and computational findings identify compound 17 as a promising and mechanistically well‐characterized VEGFR‐2 inhibitor, warranting further in vivo investigation.

chromene derivativesVEGFR-2 inhibitorsantiproliferative activitycancer cell lines
مقالمفتوح (مستودع)2026

Unraveling the Anti‐Arthritic Potential of Bioactive Compounds From Melaleuca alternifolia Oil: Integrated In Vivo, Molecular Docking, and Network Pharmacology Insights

Food Science & Nutrition · مجلد 14 (9) · e72328-e72328

ABSTRACT Rheumatoid arthritis (RA) is a chronic inflammatory condition that affects millions of people globally, often leading to morbidity. Recent research highlights the potential of natural products in managing arthritis symptoms and modifying disease progression. Among these, Melaleuca alternifolia oil (MAO) has emerged as a promising therapeutic option due to its anti‐inflammatory and analgesic properties. A total of 36 Sprague–Dawley rats weighing between 200 and 220 g were divided into six groups ( n = 6). On day 0, arthritis was induced by CFA. On day 8, treatment started and lasted till day 28. Paw edema and arthritic score were measured. Moreover, hematological, histological, and biochemical parameters were evaluated. The mRNA expression levels of anti‐inflammatory cytokine IL‐4 and pro‐inflammatory cytokines such as TNF‐α, IL‐6, NF‐κB, and IL‐1β were measured using real‐time polymerase chain reaction (qPCR). ELISA was used to detect PGE2 levels. Network pharmacology was used to evaluate the hub genes between the phytocompounds and rheumatoid arthritis. Molecular docking and scoring calculations were done for the top matched hub genes for moderate confirmations between phytocompounds and targets. GC–MS analysis was also performed to identify potential anti‐inflammatory constituents present in the plant oil. Treatment with MAO effectively reduced paw edema and swelling. Histopathological examinations demonstrated significant improvement in the treatment groups. Biochemical parameters such as creatinine, urea, alanine aminotransferase (ALT), and alkaline phosphatase (ALP) did not significantly alter, and hematological parameters such as red blood cells (RBC), white blood cells (WBC), hemoglobin (Hb), and platelet count were restored in the treated group. The mRNA expression of anti‐inflammatory cytokines, including IL‐4, was upregulated, and pro‐inflammatory biomarkers such as TNF‐α, IL‐1β, IL‐6, and NF‐κB were significantly downregulated in the arthritic control group. Furthermore, treatment with MAO significantly reduced PGE2 levels. Network pharmacology indicated the hub genes and several biological processes, molecular functions, cellular components, and KEGG pathways that are involved in rheumatoid arthritis. Molecular docking was performed against hub genes such as AKT1, BCL‐2, MAPK3, and MMP9 that are involved in various pro‐inflammatory cytokine formation and pathophysiology of rheumatoid arthritis. GC–MS analysis of the plant's oil revealed the presence of numerous anti‐inflammatory and antirheumatic phytochemicals. MAO possesses considerable anti‐arthritic properties by downregulating pro‐inflammatory biomarkers such as IL‐1β, NF‐κB, IL‐6, TNF‐α, and upregulating anti‐inflammatory IL‐4. Further investigations are needed to explore its potential as a natural therapeutic option for treating RA.

tea tree oilrheumatoid arthritisanti-inflammatory activityCFA-induced arthritis
مقالوصول مغلق2026

Preventive effects of quercetin and N-acetylcysteine, alone and combined, against acetaminophen-induced hepatotoxicity in rats: associations with COX-2/TGF-β1 and Nrf2/HO-1 mRNA expression

Toxicology Research · مجلد 15 (5)

Abstract This study evaluated the preventive effects of quercetin (QR) and N-acetylcysteine (NAC), alone or combined, in a rat model of acute acetaminophen (APAP)-induced hepatotoxicity. Twenty-five male rats were allocated to five groups (n = 5): control, APAP, NAC + APAP, QR + APAP, and NAC + QR + APAP. NAC (150 mg/kg) and/or QR (50 mg/kg) were administered orally for 7 days before a single oral APAP dose (2 g/kg). Serum liver-function indices, lipid profile, circulating TNF-α and IL-6, hepatic oxidative-status indices, hepatic COX-2, TGF-β1, Nrf2, and HO-1 mRNA abundance, histopathology, and IL-1β immunohistochemistry were assessed. APAP increased ALT, AST, triglycerides, total cholesterol, TNF-α, IL-6, and hepatic MDA, while decreasing total protein, albumin, HDL-C, GSH, CAT, SOD, and GPx. It also increased COX-2 and TGF-β1 transcripts and decreased Nrf2 and HO-1 transcripts. Pretreatment with NAC or QR partially attenuated these changes, whereas their combination generally produced values closer to control. The combined regimen also reduced histological injury and IL-1β immunoreactivity relative to APAP. These findings support a preventive association between combined NAC/QR exposure and improved redox and inflammatory indices. Because protein abundance, Nrf2 nuclear translocation, treatment after injury, and treatment-only controls were not evaluated, the data do not establish pathway activation, pharmacological synergy, or therapeutic efficacy after established overdose.

quercetinN-acetylcysteineacetaminophen hepatotoxicitydrug-induced liver injury
مقالوصول مفتوح2026

Protective effect of hesperetin against myelosuppression and splenic inflammation via modulating TLR4/MYD88/NF-κB signaling: molecular docking and experimental validation

Frontiers in Pharmacology · مجلد 17 · 1826774-1826774

Introduction: Myelotoxicity is a common adverse effect of vincristine and other chemotherapeutic drugs. Hesperetin is a bioactive flavanone with anti-inflammatory activity. This study was planned to examine the hesperetin protecting effect against vincristine induced myelosuppression and splenic inflammation in mice and test whether this effect is mediated through the suppression of Toll-like receptor 4 (TLR4)/myeloid differentiation primary response-88 (MYD88)/nuclear factor-kappa B (NF-κB) signaling pathways. Methods: Bioinformatics tools were used to establish the rationale of the study and molecular docking defined the potential binding of hesperetin to TLR4. Mice were allocated into different experimental groups: Group 1: was the saline mice, Group 2; mice were injected with vincristine (0.1 mg/kg, i. p) for 5 days per week, Group 3; mice received vincristine (as in Group 2) plus hesperetin (100 mg/kg, p. o.) and Group 4; mice received hesperetin (100 mg/kg, p. o.) only; the experiment continued for 2 weeks. Results: 9/L in the saline group, p less than 0.05) and bone marrow hypocellularity (dropped to ∼30-40% compared to 95%-100% in the saline group). The spleens showed white pulp lymphoid depletion, red pulp mild hypocellularity, greater immunostaining for MYD88, and greater content for TLR4, NF-κB, MYD88, TNF-α and IL-1β proteins. Results of molecular docking showed that hesperetin is an interesting complementarity with the TLR4/MD2 interface which was a good rationale for the experimental validation. The mouse experiment showed that hesperetin prevented the decrease hematological parameters, enhanced the bone marrow cellularity to 80%-90%, and the splenic architecture. Hesperetin further inhibited the increases in the target proteins (TLR4, NF-κB, MYD88, TNF-α and IL-1β) significantly. Discussion: The present data documents the novel role of hesperetin in mitigating myelotoxicity of vincristine through modulation of TLR4/MYD88/NF-κB signaling and a direct binding to TLR4 was proposed by molecular docking. This highlights possible usefulness of this combination after adequate clinical studies.

hesperetinvincristinemyelosuppressionsplenic inflammation
مقالمفتوح (مستودع)2026

N ‐Acetyl Cysteine Mitigates d ‐Ribose‐Induced Protein Glycation and Aggregation Through Multiple Protective Mechanisms

IUBMB Life · مجلد 78 (9) · e70126-e70126

Advanced glycation end-products (AGEs) arise from non-enzymatic reactions between reducing sugars and proteins, contributing to oxidative stress and metabolic dysfunction. Excessive AGE accumulation is implicated in chronic diabetic complications and may also be relevant to acute metabolic disturbances encountered in emergency medicine. N-acetylcysteine (NAC), a naturally occurring antioxidant found in Allium species, has demonstrated potential to attenuate oxidative and glycation-mediated damage. The effect of NAC on d-ribose-induced glycation of bovine serum albumin (BSA) was investigated using multiple physicochemical and spectroscopic techniques. AGE formation was assessed by measuring hyperchromicity, early glycation products (ketoamines), carbonyl content, hydroxymethylfurfural (HMF) levels, and fluorescent AGEs. The protective effect of NAC was further evaluated by determining free lysine and arginine contents. Protein aggregation and conformational changes were analyzed using Congo Red binding and fluorescence assays including thioflavin-T and 1-anilinonaphthalene-8-sulfonic acid. NAC significantly inhibited d-ribose-mediated glycation of BSA in a concentration-dependent manner. Treatment with NAC resulted in reduced hyperchromicity, decreased ketoamine formation, and lower carbonyl, HMF, and fluorescent AGE levels. NAC preserved protein integrity by maintaining higher free lysine and arginine contents. In addition, NAC markedly attenuated glycation-induced protein aggregation, as evidenced by reduced Congo Red binding and diminished thioflavin-T and ANS fluorescence, with maximal protection observed at 300 μM. NAC exhibits pronounced anti-glycation and anti-aggregation effects by limiting oxidative stress and glycation-mediated protein modification. These findings demonstrate that NAC effectively attenuates d-ribose-induced glycation and protein aggregation in vitro and provide mechanistic insights into its anti-glycation properties through multiple complementary biochemical mechanisms. Further studies are warranted to evaluate its biological relevance in more complex experimental models.

N-acetylcysteineadvanced glycation end productsprotein glycationprotein aggregation
مقالمفتوح (مستودع)2026

A Topological and Spatial Analysis of FDA‐Approved Drugs, Blood‐Brain Barrier Permeants, Natural Products, and Metabolites

ChemMedChem · مجلد 21 (17) · e70462-e70462

In this study, we present a comprehensive structural analysis of four distinct chemical libraries: FDA‐approved drugs, blood‐brain barrier (BBB) permeable agents, natural products (UNPDA), and human metabolites. Our multidimensional profiling reveals fundamental divergences in molecular architecture. While synthetic drugs (FDA) and CNS‐active agents (BBB) follow continuous, Gaussian‐like distributions for carbon hybridization, natural products exhibit biosynthetic quantization, discrete, high‐intensity abundance spikes at C19 and C30, corresponding to steroid and triterpene scaffolds. Stereochemical analysis identifies a chirality‐structure lock in natural products, where stereoisomer density peaks significantly at these same integers (Avg. 3.53 isomers/mol), a complexity feature absent in the diffuse distribution of synthetic libraries. Topologically, we identify hyper‐globularity as a distinct signature for CNS permeability. Radial distribution function (RDF) analysis demonstrates that BBB agents possess a highly compressed aliphatic core, packing 93.2% of their sp 3 mass within a 3 Å radius, compared to 84.4% for general FDA therapeutics. Furthermore, elemental profiling reveals a heteroatom gap: synthetic drugs exhibit a high electronegative atom‐to‐carbon ratio (0.43), whereas BBB agents (0.33) converge with the lipophilic profile of natural products (0.32), suggesting that CNS penetration requires a biomimetic reduction in polarity. These findings establish new quantitative metrics for designing neuro‐compatible and biomimetic pharmacophores.

blood-brain barrier permeabilitynatural productshuman metabolitesFDA-approved drugs
مقالوصول مغلق2026

A robust and lightweight ECC-based authentication protocol for IoT-driven e-healthcare systems with provable security analysis

Journal of the Chinese Institute of Engineers · 1-21

The Internet of Things (IoT), sensors, and wearables collect real-time physiological vitals from the patient’s body and transmit them to their destination through a wireless channel prone to several threats, including replay, denial-of-service (DoS) attacks, and pose privacy issues. However, if all the involved entities become securely authenticated, this, in turn, can minimize the mentioned threats and ensure the confidentiality, integrity, and privacy of patient-sensitive information. Therefore, this article presents a robust and lightweight authentication protocol for the IoT-driven e-healthcare system by utilizing Elliptic Curve Cryptographic (ECC) technique in which all the sensors/wearables or IoT devices that are operationalized in the e-healthcare system for real-time patient monitoring can be securely connected to the gateway to show strong resistance to all the known cyber-threats in such hostile environments and maintain patient privacy, confidentiality, integrity, and authorization. The security analysis was conducted using the well-known and widely used BAN (Burrows – Abadi – Needham) logic, ProVerif simulation, AVISPA validation, and ROM analysis. While the performance evaluation of the proposed protocol has been conducted by considering computation and communication costs, an 81.01% improvement has been recorded in terms of communication cost, and a 92.26% improvement in computation overhead, when compared with prior works.

lightweight authentication protocolelliptic curve cryptographyInternet of Thingse-health
مقالمفتوح (مستودع)2026

Assessment of Knowledge and Practice of Food Safety and Hygiene Among Food Vendors in Selected Primary Schools Within Sokoto Metropolis

American Journal of Medicine and Health Care · مجلد 1 (2) · 60-65

Foodborne diseases represent a significant public health challenge in developing countries, with contaminated food from unhygienic food vendors being a major source of morbidity and mortality, particularly among vulnerable populations, including schoolchildren. Food hygiene practices among vendors serving primary school children require a comprehensive assessment to guide health promotion and policy interventions. This study assessed the knowledge, practices, and improvement strategies for food safety and hygiene among food vendors operating in selected primary schools within Sokoto Metropolis. A descriptive cross-sectional study was conducted with 100 food vendors selected through multi-staged sampling from 20 primary schools across three local government areas in Sokoto Metropolis. Data were collected using a structured questionnaire comprising demographic information, knowledge assessment, practice evaluation, and improvement strategies. Descriptive statistics, including frequency distributions and percentages, were used for data analysis. Seventy-two per cent of food vendors demonstrated knowledge of food safety and hygiene principles. The majority engaged in good food safety practices, with 88% using clean utensils when serving food, 82% washing vegetables thoroughly before preparation, and 80% maintaining clean school premises. Key improvement strategies identified included attending food safety training programs (14%), avoiding cross-contamination (12%), and maintaining appropriate food storage temperatures (12%). Food vendors in primary schools demonstrated adequate knowledge and reasonably good food safety practices. However, systematic food safety training programs, regular environmental health inspections, and the provision of adequate facilities for handwashing and waste disposal are essential for sustaining and improving food hygiene standards. School health programs should be strengthened through collaboration between educational and health authorities.

food safetyfood hygienefood vendorselementary school
مقالوصول مفتوح2026

Intracranial Hemorrhage as a Life-Threatening Complication of Congenital Factor VII Deficiency Associated With Inhibitor Development: A Case Report

Cureus · مجلد 18 (8) · e114964-e114964

Congenital factor VII (FVII) deficiency is an uncommon autosomal recessive bleeding disorder with highly variable clinical expression. Although most patients present with mild to moderate bleeding symptoms, severe cases may manifest with life-threatening hemorrhage, particularly intracranial bleeding. The emergence of inhibitors against exogenous FVII is exceedingly rare but poses a significant therapeutic challenge because of treatment refractoriness and an increased risk of major bleeding. We describe a five-year-old Saudi girl with severe congenital FVII deficiency diagnosed in the neonatal period who developed inhibitory antibodies while on regular recombinant activated FVII (rFVIIa) prophylaxis. She presented with acute intracranial hemorrhage and was successfully managed with rFVIIa despite the presence of a high-titer inhibitor. This report highlights the importance of early recognition of inhibitor development in FVII deficiency and the need for individualized therapeutic approaches in rare bleeding disorders.

congenital factor VII deficiencyfactor VII inhibitorsintracranial hemorrhagerecombinant factor VIIa
مقالوصول مغلق2026

Elucidating the mechanism of ADAM10/PD-L1 interaction in pancreatic adenocarcinoma cell lines using cellular and computational analyses

Journal of Biomolecular Structure and Dynamics · مجلد 44 (16) · 7537-7551

Targeting the immune checkpoint programmed cell death-ligand 1 (PD-L1) faces diverse challenges against pancreatic ductal adenocarcinoma (PDAC), the most common type of cancer-related death. Shedding of PD-L1 from the tumor cell surface by A Disintegrin And Metalloprotease 10 (ADAM10) may impede the function of antitumor immune cells. Understanding the molecular mechanisms behind this interaction is urgently needed. This study elucidates the mechanism of ADAM10/PD-L1 interaction in the pancreatic adenocarcinoma cell line, PANC-1, using cellular assays, molecular docking, and molecular dynamics (MD) simulations. Cellular assays validated that ADAM10 interacts with PD-L1 and sheds the PD-L1 from the cell surface, generating soluble PD-L1 (sPD-L1). Concurrently, the docking results identified critical residues and potential contact points, providing strong evidence for a stable and specific interaction between ADAM10 and PD-L1. The molecular dynamics (MD) simulations further confirmed the structural integrity of the ADAM10/PD-L1 complex, predicting its compactness and stability. These results elucidate how ADAM10 recognizes and interacts with PD-L1, facilitating its cleavage. Future work can leverage these findings to develop potent cancer immunotherapies that inhibit the ADAM10/PD-L1 interaction and the generation of soluble molecules.

ADAM10PD-L1pancreatic ductal adenocarcinomaprotein-protein interaction
مقالوصول مغلق2026

The effect of losartan nanoparticles vs losartan on TIMP1 and α-SMA immunohistochemical and gene expression in carbon tetrachloride-induced liver fibrosis

Biotechnic & Histochemistry · مجلد 101 (7) · 405-418

Liver fibrosis is characterized by scar formation as a response to injury. Although many drugs have demonstrated antifibrotic efficacy in vitro and in animal models, effectively translating these into effective clinical therapies remains a challenge. Nanotechnology offers potential therapeutic approaches for treating liver fibrosis. This study aimed to assess and compare the antifibrotic effects of losartan and losartan nanoparticles (LP-NPs) on CCl4-induced liver fibrosis in rats.Thirty-two adult male Sprague-Dawley rats were divided into four groups: a control group, a CCl4-induced fibrosis group, a losartan-treated group, and an LP-NPs-treated group. Liver fibrosis was induced by CCl4 injections over six weeks. Losartan or LP-NPs were orally administered for four weeks. At the conclusion of the study, rats were euthanized, and blood samples were collected for liver enzyme assessment. Liver specimens were subjected to histopathological examination (H&E, Sirius red staining), immunohistochemistry (α-SMA and TIMP1), and quantitative real-time PCR (qRT-PCR) for gene expression analysis of α-SMA and TIMP1. Morphometrical studies quantified collagen areas in Sirius red-stained sections and optical density of α-SMA and TIMP1 in immunohistochemically stained sections.The results showed that CCl4 induced significantly elevated liver enzymes, severe distortion of hepatic architecture, marked steatosis and fibrosis. Additionally, there was an increase in collagen content, accompanied by strong positive immunostaining and upregulated gene expression of α-SMA and TIMP1. Both losartan and LP-NPs treatments significantly improved these parameters compared to the CCl4-only group. Notably, LP-NPs demonstrated significantly greater improvements in liver enzyme levels, collagen percentage area, and the gene expression of α-SMA and TIMP1 compared to the standard losartan group. However, no significant difference was observed between the two treatments in α-SMA optical density.In conclusion, this investigation demonstrates that nanoformulation significantly enhanced losartan’s antifibrotic efficacy. LP-NPs improved liver function and histological architecture, reduced collagen content after CCl4 administration, and demonstrated greater therapeutic efficacy than conventional losartan.

losartanliver fibrosiscarbon tetrachlorideantifibrotic therapy